May inform updated lipid targets in dyslipidaemia; leaves open real-world outcome validation across populations.
Esc . . Esc.
No takes yet. Share an insight, caveat, or question.
Mach et al. (2020) studied this question. The 2019 ESC/EAS guidelines provide comprehensive recommendations for lipid modification to reduce cardiovascular risk in patients with dyslipidaemias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: